ISSN: 1873-4316 (Online)
ISSN: 1389-2010 (Print)


Volume 18, 15 Issues, 2017


Download PDF Flyer




Current Pharmaceutical Biotechnology

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 152nd of 255 in

    Pharmacology & Pharmacy

  • 213th of 290 in

    Biochemistry & Molecular Biology


Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:

Davide Prosperi


Department of Biotechnology and Bioscience
University of Milano-Bicocca
Milano
Italy


View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 2.459
5 - Year: 2.33
Browse Contents
Select Volume:


Select Issue:


Select Article:


Abstracted/Indexed in




Endorsement(s)

"Current Pharmaceutical Biotechnology presents the latest developments in the area of biotechnology. This is strongly recommended."

Robert Huber
Nobel Laureate

Forthcoming Special Issue(s)

ANALYTICAL ADVANCES IN CLINICAL AND FORENSIC TOXICOLOGY


Guest Editor(s): Marzena Laskowska
Tentative Publication Date: March, 2018
Submit Abstract via Email Download Description
Published Special Issue(s)

DIAGNOSTIC AND PROGNOSTIC INSIGHTS OF BIOMARKERS IN CARDIOVASCULAR DISEASES


Current Pharmaceutical Biotechnology, Volume 18, Number 06
Guest Editor(s): Michael Behnes, Ibrahim Akin

Authors' Comments
It was a great experience for me working with Bentham Science Publishers because of the following reasons:
-High quality services
-Professionalism
-Cordiality
-Great and kind cooperation and collaboration

Dr. Helmy Selman
(The CIVF Center Doha Center Clinic Hospital Doha, Qatar)



Current Pharmaceutical Biotechnology

,

Volume 18

-

Number 6



Drs. Eric Betzig, Stefan W. Hell and William E. Moerner share the 2014 chemistry Nobel for the development of super-resolved fluorescence microscopy.

“The Royal Swedish Academy of Sciences has decided to award the 2014 Nobel Prize in Chemistry to Dr. Eric Betzig at Howard Hughes Medical Institute, Ashburn, U.S.A.; Professor Stefan Hell at Max Planck Institute for Biophysical Chemistry, Göttingen, and the German Cancer Research Center, Heidelberg, Germany; and Professor William Moerner at Stanford University, Stanford, U.S.A., for the development of super-resolved fluorescence microscopy.”

Much research effort was needed to realize that single-cell and single-molecule based approaches directly affect improvements in human health. However, many of these laboratory technologies are not available in a cheap and easy version. Single-molecule based fluorescence imaging and detection have the advantages of a small volume platform, digital analysis, elimination of processing steps, real-time measurements and automation of sample preparation. In 2015, Current Pharmaceutical Biotechnology will continue in this direction with quality papers that can be expected to trigger further investigations.

Drs. Eric Betzig and William E. Moerner also developed methods and biotechniques which have enabled the study of single molecules in ongoing chemical reactions in living cells. Because now it is possible to see individual macromolecules moving about in a living cell, we can study chemistry at a single-molecule level and in real life. And this is very important to chemistry because chemistry has traditionally been about studying a large number of molecules and the effect that they have. The journal Current Pharmaceutical Biotechnology has published on this research and has been at the forefront for over more than one decade. Curr. Pharm. Biotechnol. has published thematic issues, original research and review articles about the entirely new possibilities for chemistry and for biochemistry by eminent scientists from around the world, some examples:

Advertisement

Related Journals




Related eBooks



Webmaster Contact: info@benthamscience.org Copyright © 2017 Bentham Science